Medplus Health Services announced that Parag Jain company secretary and compliance officer of the company has resigned with effect from 14 January 2022 In addition to the above Parag Jain will also cease to be the company secretary of Optival Health Solutions material subsidiary of the company and Wynclark Pharmaceuticals subsidiary of the company
BMW Industries announced the demise of Debasish Basu DIN-00581141 Independent Director of the Company on 14 January 2022
Integrated Hitech will hold a meeting of the Board of Directors of the Company on 19 January 2022
Glenmark Pharmaceuticals announced that its fully owned subsidiary Glenmark Specialty SA Switzerland received FDA approval on its New Drug Application NDA for Ryaltris an innovative fixeddose metered prescription combination drug product nasal spray for the treatment of symptoms of Seasonal Allergic Rhinitis in adults and pediatric patients 12 years of age and older in the United States Ryaltris will be marketed and distributed in the […]
Greencrest Financial Services will hold a meeting of the Board of Directors of the Company on 8 February 2022
Abhishek Finlease will hold a meeting of the Board of Directors of the Company on 24 January 2022
HDFC Bank has allotted 285700 equity shares under ESOP The paid up share capital of the Bank will accordingly increase from Rs 5542399476 equity shares of Re1 each to Rs 5542685176 equity shares of Re1 each
Aditya Birla Fashion and Retail today announced a strategic partnership with Indias leading designer Masaba Gupta to build a gen-next focused fashion and lifestyle business under the popular and contemporary brand Masaba by way of entering into a Binding Term sheet to acquire 51Percentage stake in the entity The proposed acquisition is subject to signing of definitive agreements completion of closing conditions precedent to be […]
Jyothy Labs will hold a meeting of the Board of Directors of the Company on 21 January 2022
Cadila Healthcare Limited has informed the Exchange regarding Compliance of SEBI Circular dated November 3, 2021. Notice to shareholders of the Company holding shares in physical form with regard to norms for furnishing PAN, KYC details and Nomination
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
